Thanks for that update, greenstreets. I always appreciate management that responds to shareholder inquiries. Also, very good to hear that there is no planning for any RS at the current low pps levels. After BKYI has had some significant growth and pps elevation then that may be a quick route to a higher profile listing for the stock but nothing to be concerned about right now.
BIO-key is getting some nice coverage in the Biometrics press this week for their new partnership with 2FA. Here's another article that was published by BiometricUpdate.com.
BIO-key International announced that 2FA, Inc., a veteran-owned cybersecurity company providing enterprise multifactor authentication and single sign-on solutions, has licensed BIO-key’s fingerprint-based biometric authentication technology platform and incorporated it into 2FA’s 2FA ONE Authentication platform.
2FA plans to begin delivering BIO-key based solutions to customers in the first quarter.
2FA’s upgrade to BIO-key insulates it from the rapidly-evolving fingerprint scanner marketplace, gives 2FA end-users a mix and match choice between BIO-key’s over 40 supported fingerprint scanners, NIST-certified accuracy and 1-to-many identification capabilities, even among large enterprise populations.
“The strategic decision to leverage BIO-key’s technology within our solution came after months of due diligence to find the best-of-breed biometric authentication suite to support our current and future customers,” stated, Greg Salyards, 2FA, Inc. CEO. “With over 2,500,000 end-users worldwide who depend on our solution every day to access critical and protected information, the decision to incorporate BIO-key’s technology into our authentication platform was crucial to ensure the highest security and customer satisfaction. 2FA supports over 250,000 public sector end-users who rely upon our solution for streamlined, yet compliant access to criminal justice information provided by state and federal agencies. Our plan is to immediately leverage BIO-key’s technology for HIPAA- and EPCS-compliant authentication at our largest healthcare customers, ranging in size from 10,000 to over 20,000 users.”
“BIO-key is thrilled to welcome a company with 2FA’s track record of success to our list of innovative customers,” stated Jim Sullivan, SVP Global Sales, BIO-key. “We are especially pleased that an authentication provider with 2FA’s years of biometric authentication experience has elected to take their biometric offering to the next level by adding BIO-key’s interoperability, 1-to-many identification, and NIST-tested accuracy. We look forward to working with 2FA to bring this solution to their sizable existing customer base,” added Sullivan.
Microsoft recently featured BIO-key as its only biometrics solution partner on its 12-city roadshow as part of the U.S. launch of Windows 10 for Business and the company reported that more than 40 percent of attendees met with BIO-key and requested engagement regarding BIO-key products for Windows 10 and Hello, Microsoft’s native biometric logon option.
News 
Market Data 
Discover 
